Overview
Publication Venue For
2020 American College of Rheumatology Guideline for the Management of Gout.
2020
Reply..
72:736-738.
2020
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
72:461-488.
2020
Assessing Rheumatoid Arthritis Disease Activity With Patient-Reported Outcomes Measurement Information System Measures Using Digital Technology.
72:553-560.
2020
Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
72:561-576.
2020
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.
72:149-162.
2020
Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat-to-Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology.
72:166-175.
2020
Association of Diabetes Mellitus and Biomarkers of Abnormal Glucose Metabolism With Incident Radiographic Knee Osteoarthritis.
72:98-106.
2020
Step Rate and Worsening of Patellofemoral and Tibiofemoral Joint Osteoarthritis in Women and Men: The Multicenter Osteoarthritis Study.
72:107-113.
2020
2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures.
71:1540-1555.
2019
Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
71:1600-1605.
2019
International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group.
71:1556-1565.
2019
Screening of Hyperlipidemia Among Patients With Rheumatoid Arthritis in the United States.
71:1593-1599.
2019
Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus.
71:1647-1652.
2019
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
71:1285-1299.
2019
Association of Varus Knee Thrust During Walking With Worsening Western Ontario and McMaster Universities Osteoarthritis Index Knee Pain: A Prospective Cohort Study.
71:1353-1359.
2019
Low Persistence Rates in Patients With Rheumatoid Arthritis Treated With Triple Therapy and Adverse Drug Events Associated With Sulfasalazine.
71:1326-1335.
2019
Sex-Specific Influence of Quadriceps Weakness on Worsening Patellofemoral and Tibiofemoral Cartilage Damage: A Prospective Cohort Study.
71:1360-1365.
2019
Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids.
71:1249-1254.
2019
Thresholds in the Relationship of Quadriceps Strength With Functional Limitations in Women With Knee Osteoarthritis.
71:1186-1193.
2019
Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes.
71:1224-1233.
2019
Concurrent Change in Quadriceps Strength and Physical Function Over Five Years in the Multicenter Osteoarthritis Study.
71:1044-1051.
2019
Long-Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five-Year Observational Study.
71:993-1003.
2019
Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients.
71:1004-1018.
2019
Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort.
71:893-902.
2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis.
71:703-716.
2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
71:717-734.
2019
American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus.
71:579-590.
2019
Patient- and Rheumatologist- Perspectives Regarding Challenges to Achieving Optimal Disease Control in Rheumatoid Arthritis.
2019
Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.
71:427-434.
2019
A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator Trials.
71:319-322.
2019
Chronic Inflammation in Rheumatoid Arthritis and Mediators of Skeletal Muscle Pathology and Physical Impairment: A Review.
71:173-177.
2019
Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis–Associated and idiopathic chronic anterior uveitis.
71:482-491.
2019
Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study.
71:80-87.
2019
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
71:2-29.
2019
Clinical Characteristics and Factors Associated With Disability and Impaired Quality of Life in Children With Juvenile Systemic Sclerosis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
70:1806-1813.
2018
Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus?.
70:1694-1699.
2018
Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study.
70:1653-1660.
2018
Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
70:1478-1487.
2018
Evaluation of a Methodologic Approach to Define an Inception Cohort of Rheumatoid Arthritis Patients Using Administrative Data.
70:1541-1545.
2018
Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach.
70:1294-1302.
2018
Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout.
70:659-671.
2018
Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis.
70:679-684.
2018
Toward Establishing a Standardized Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis.
70:758-767.
2018
Affect and Incident Participation Restriction in Adults With Knee Osteoarthritis.
70:542-549.
2018
Delays to Care in Pediatric Lupus Patients: Data From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
70:420-427.
2018
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
70:409-419.
2018
Development and Pilot Testing of Multimedia Patient Education Tools for Patients With Knee Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis.
70:213-220.
2018
Septic Arthritis in Emergency Departments in the US: A National Study of Health Care Utilization and Time Trends.
70:320-326.
2018
Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee Arthroplasty.
69:1845-1854.
2017
Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' Perspectives.
69:1724-1732.
2017
Serious Infections in Childhood-Onset Systemic Lupus Erythematosus: Using Administrative Claims Data to Investigate Disease Outcomes.
69:1617-1619.
2017
Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.
69:1526-1534.
2017
Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.
69:1400-1406.
2017
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
69:1111-1124.
2017
Clinical Practice Guidelines: Incorporating Input From a Patient Panel.
69:1125-1130.
2017
Association of Anti–3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
69:1088-1094.
2017
Perceived Community Environmental Factors and Risk of Five-Year Participation Restriction Among Older Adults With or at Risk of Knee Osteoarthritis.
69:952-958.
2017
Knee Pain and Structural Damage as Risk Factors for Incident Widespread Pain: Data From the Multicenter Osteoarthritis Study.
69:826-832.
2017
Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.
69:313-322.
2017
Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis.
68:1803-1811.
2016
Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis.
68:1751-1757.
2016
Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context.
68:1787-1794.
2016
Development of the American College of Rheumatology’s Rheumatoid Arthritis Electronic Clinical Quality Measures.
68:1579-1590.
2016
Effect of Knee Extensor Strength on Incident Radiographic and Symptomatic Knee Osteoarthritis in Individuals With Meniscal Pathology: Data From the Multicenter Osteoarthritis Study.
68:1640-1646.
2016
Are Pressure Time Integral and Cumulative Plantar Stress Related to First Metatarsophalangeal Joint Pain? Results From a Community-Based Study.
68:1232-1238.
2016
Treatment Algorithms for Patients with Systemic Lupus Erythematosus: Comment on the Article by Muangchan et al.
68:1385.
2016
Symptoms of Knee Instability as Risk Factors for Recurrent Falls.
68:1089-1097.
2016
Relation of Step Length to Magnetic Resonance Imaging-Detected Structural Damage in the Patellofemoral Joint: The Multicenter Osteoarthritis Study.
68:776-783.
2016
Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.
68:667-672.
2016
Reply.
68:725-726.
2016
Enhanced Pain Sensitivity among Individuals with Symptomatic Knee Osteoarthritis: Potential Sex Differences in Central Sensitization.
68:472-480.
2016
Exercise Medicine for Osteoarthritis: Research Strategies to Maximize Effectiveness.
68:288-291.
2016
Incomplete Systemic Lupus Erythematosus: Early Diagnosis or Overdiagnosis?.
68:285-287.
2016
Longitudinal Course of Physical Function in People with Symptomatic Knee Osteoarthritis: Data from the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative.
68:325-331.
2016
When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.
68:26-35.
2016
Herpes Zoster Reactivation in Patients with Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
67:1671-1678.
2015
Can an intensive diet and exercise program prevent knee pain among overweight adults at high risk?.
67:965-971.
2015
20-Year-Old Amish Woman With Abdominal Pain, Retroperitoneal Mass, and Hyperlipidemia.
67:447-451.
2015
Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: A substudy.
67:929-939.
2015
Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.
67:1345-1353.
2015
Does hospital volume predict outcomes and complications after total shoulder arthroplasty in the US?.
67:885-890.
2015
Electrocardiographic findings in systemic lupus erythematosus: Data from an international inception cohort.
67:128-135.
2015
Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.
67:624-632.
2015
Novel method to collect medication adverse events in juvenile arthritis: Results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.
67:529-537.
2015
Proceedings from the American College of Rheumatology Reproductive Health Summit: The management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.
67:313-325.
2015
Racial and Ethnic Differences in Mortality and Cardiovascular Events among Patients with End-Stage Renal Disease Due to Lupus Nephritis.
67:1453-1462.
2015
Reply.
67:1041-1042.
2015
Rheumatoid arthritis is associated with higher ninety-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: A cohort study.
67:718-724.
2015
Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
67:731-736.
2015
What is the relationship between morning symptoms and measures of disease activity in patients with rheumatoid arthritis?.
67:1202-1209.
2015
Use of Oral and Subcutaneous Methotrexate in Rheumatoid Arthritis Patients in the United States.
66:1604-1611.
2014
Complementary and alternative medicine use in African Americans with rheumatoid arthritis.
66:180-189.
2014
Adding canakinumab to the childhood arthritis and rheumatology research alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et al.
66:1430-1431.
2014
Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus.
66:1374-1379.
2014
Daily walking and the risk of incident functional limitation in knee osteoarthritis: An observational study.
66:1328-1336.
2014
Development and retrospective validation of the juvenile spondyloarthritis disease activity index.
66:1775-1782.
2014
Development and validation of the lupus impact tracker: A patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus.
66:1542-1550.
2014
Imaging of the temporomandibular joint in juvenile idiopathic arthritis.
66:47-54.
2014
Linkage of a de-identified united states rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.
66:1790-1798.
2014
Reply.
66:1271-1272.
2014
Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis.
66:990-997.
2014
Socioeconomic disparities in the health of African Americans with rheumatoid arthritis from the southeastern United States.
66:1808-1817.
2014
Time trends in the characteristics of patients undergoing primary total knee arthroplasty.
66:897-906.
2014
Better functional and similar pain outcomes in osteoarthritis compared to rheumatoid arthritis after primary total knee arthroplasty: A cohort study.
65:1936-1941.
2013
Psychological profiles and pain characteristics of older adults with knee osteoarthritis.
65:1786-1794.
2013
Tumor necrosis factor, tuberculosis, testing, and treatment: Teeing up the questions.
65:1719-1721.
2013
Tumor necrosis factor, tuberculosis, testing, and treatment: teeing up the questions..
65:1719-1721.
2013
2013 Update of the 2011 American college of rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.
65:1551-1563.
2013
Patient perspectives on achieving treat-to-target goals: A critical examination of patient-reported outcomes.
65:1707-1712.
2013
Serum urate levels and consumption of common beverages and alcohol among chinese in Singapore.
65:1432-1440.
2013
Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases.
65:1085-1094.
2013
Sex and surgical outcomes and mortality after primary total knee arthroplasty: A risk-adjusted analysis.
65:1095-1102.
2013
Clinically important body weight gain following knee arthroplasty: A five-year comparative cohort study.
65:669-677.
2013
Reply.
65:832-833.
2013
Gout-related health care utilization in US emergency departments, 2006 through 2008.
65:571-577.
2013
Physicians' explanations for apparent gaps in the quality of rheumatology care: Results from the US Medicare Physician Quality Reporting System.
65:235-243.
2013
Preferences for arthritis interventions: Identifying similarities and differences among African Americans and whites with osteoarthritis.
65:203-211.
2013
Choosing wisely: The American College of Rheumatology's top 5 list of things physicians and patients should question.
65:329-339.
2013
Patient race and surgical outcomes after total knee arthroplasty: an analysis of a large regional database..
65:414-420.
2013
Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program.
65:1743-1751.
2013
Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data.
64:1855-1863.
2012
Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis.
64:1819-1828.
2012
Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis.
64:1804-1810.
2012
Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.
64:1794-1803.
2012
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis..
64:1447-1461.
2012
2012 American college of rheumatology guidelines for management of gout. part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.
64:1431-1446.
2012
Reply.
64:1623-1624.
2012
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.
64:1462-1470.
2012
Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high-versus lower-risk rheumatoid arthritis patients.
64:1480-1489.
2012
Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.
64:1282-1291.
2012
Adherence with intravenous zoledronate and intravenous ibandronate in the United States medicare population.
64:1054-1060.
2012
Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis.
64:1001-1010.
2012
Patterns of compartment involvement in tibiofemoral osteoarthritis in men and women and in whites and African Americans.
64:847-852.
2012
Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort..
64:704-712.
2012
Predicting future response to certolizumab pegol in rheumatoid arthritis patients: features at 12 weeks associated with low disease activity at 1 year..
64:658-667.
2012
Rheumatoid arthritis disease activity measures: American college of rheumatology recommendations for use in clinical practice.
64:640-647.
2012
Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases.
64:612-615.
2012
2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.
64:625-639.
2012
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
64:132-137.
2012
Reply.
64:157-158.
2012
When it hurts, a positive attitude may help: Association of positive affect with daily walking in knee osteoarthritis. Results from a multicenter longitudinal cohort study.
64:1312-1319.
2012
Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.
63:1680-1690.
2011
Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: Experience from a large US cohort.
63:1672-1679.
2011
Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.
63:1642-1653.
2011
Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplasty.
63:1471-1476.
2011
Changes in cotherapies after initiation of disease - Modifying antirheumatic drug therapy in patients with rheumatoid arthritis.
63:1415-1424.
2011
Quadriceps weakness, patella alta, and structural features of patellofemoral osteoarthritis.
63:1391-1397.
2011
Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans.
63:1365-1374.
2011
Reply.
63:1355.
2011
Reply.
63:1353.
2011
Decreased live births in women with systemic lupus erythematosus.
63:1068-1072.
2011
Disparities in post-acute rehabilitation care for joint replacement.
63:1020-1030.
2011
Patient understanding and satisfaction in informed consent for total knee arthroplasty: A randomized study.
63:1048-1054.
2011
Estimation of minimum clinically important difference for pain in fibromyalgia.
63:821-826.
2011
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features..
63:465-482.
2011
Defining quality of care in rheumatology: The American College of rheumatology white paper on quality measurement.
63:2-9.
2011
Measuring process of arthritis care: A proposed set of quality measures for the process of care in juvenile idiopathic arthritis.
63:10-16.
2011
Alpha 1-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis.
62:3760-3767.
2010
Associations of cigarette smoking with rheumatoid arthritis in African Americans.
62:3560-3568.
2010
Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans.
62:3547-3553.
2010
Converting modified Health Assessment Questionnaire (HAQ), multidimensional HAQ, and HAQII scores into original HAQ scores using models developed with a large cohort of rheumatoid arthritis patients.
62:1481-1488.
2010
A national survey of veterans affairs rheumatologists for relevance of quality of care indicators for gout management.
62:1306-1311.
2010
The independent effect of pain in one versus two knees on the presence of low physical function in a multicenter knee osteoarthritis study.
62:938-943.
2010
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus.
62:881-887.
2010
Radiographic severity of rheumatoid arthritis in African Americans: Results from a multicenter observational study.
62:624-631.
2010
Report of the American College of Rheumatology Pain Management Task Force.
62:590-599.
2010
Development and initial validation of a self-assessed lupus organ damage instrument.
62:559-568.
2010
Reply.
62:581.
2010
Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.
62:393-400.
2010
Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity.
62:101-107.
2010
Value of assessing the fifth metatarsophalangeal joint in patients with early rheumatoid arthritis: Comment on the article by Sheane et al.
62:137.
2010
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis..
62:1515-1526.
2010
Association between patella alta and the prevalence and worsening of structural features of patellofemoral joint osteoarthritis: The multicenter osteoarthritis study.
62:1258-1265.
2010
Do worsening knee radiographs mean greater chances of severe functional limitation?.
62:1433-1439.
2010
Cartilage loss occurs in the same subregions as subchondral bone attrition: A within-knee subregion-matched approach from the multicenter osteoarthritis study.
61:1539-1544.
2009
Reply.
61:1615-1616.
2009
Skeletal health among African Americans with recent-onset rheumatoid arthritis.
61:1379-1386.
2009
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
61:1168-1178.
2009
Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII.
61:1179-1186.
2009
Effect of thigh strength on incident radiographic and symptomatic knee osteoarthritis in a longitudinal cohort.
61:1210-1217.
2009
Novel evidence-based systemic lupus erythematosus responder index.
61:1143-1151.
2009
The effects of impaired joint position sense on the development and progression of pain and structural damage in knee osteoarthritis.
61:1070-1076.
2009
Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.
61:830-839.
2009
Toward a Valid Definition of Gout Flare: Results of Consensus Exercises Using Delphi Methodology and Cognitive Mapping.
61:535-543.
2009
Is obesity a risk factor for progressive radiographic knee osteoarthritis?.
61:329-335.
2009
Rheumatology fellows' perception on training and careers in academia: The american college of rheumatology fellow research and academic training survey.
61:266-273.
2009
To the Editors.
61:285-286.
2009
Reply.
61:142.
2009
Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: A decision analysis.
59:1580-1588.
2008
Association of body composition with disability in rheumatoid arthritis: Impact of appendicular fat and lean tissue mass.
59:1407-1415.
2008
Employment and disability issues in systemic lupus erythematosus: A review.
59:1475-1479.
2008
Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.
59:1332-1340.
2008
Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: An American College of Rheumatology white paper.
59:1058-1073.
2008
Abnormal body composition phenotypes in older rheumatoid arthritis patients: Association with disease characteristics and pharmacotherapies.
59:807-815.
2008
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.
59:762-784.
2008
Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.
59:746-753.
2008
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study.
59:721-729.
2008
Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort.
59:176-180.
2008
Association of health-related quality of life with dual use of prescription and over-the-counter nonsteroidal antiinflammatory drugs.
59:227-233.
2008
Comparison of Vancouver and International League of Associations for Rheumatology classification criteria for juvenile psoriatic arthritis.
59:51-58.
2008
Measurement of fatigue in systemic lupus erythematosus: A systematic review.
57:1348-1357.
2007
Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior.
57:1539-1545.
2007
Absence of histologic evidence of synovitis in patients with Gulf War veterans' illness with joint pain.
57:1316-1323.
2007
Classification criteria in rheumatic diseases: A review of methodologie properties.
57:1119-1133.
2007
Using the short form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort.
57:986-992.
2007
Quality of care for gout in the US needs improvement.
57:822-829.
2007
A multiethnic, multicenter cohort of patients with Systemic Lupus Erythematosus (SLE) as a model for the study of ethnic disparities in SLE.
57:576-584.
2007
Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases.
57:648-655.
2007
Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease-modifying antirheumatic drugs.
57:343-346.
2007
Contributions of OMERACT to rheumatic disease research [1].
57:186.
2007
Validity of gout diagnoses in administrative data.
57:103-108.
2007
Osteoporosis in the home health care setting: A window of opportunity?.
55:971-975.
2006
Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
55:799-806.
2006
Development of classification and response criteria for rheumatic diseases.
55:348-352.
2006
Population-based assessment of adverse events associated with long-term glucocorticoid use.
55:420-426.
2006
Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis.
55:333-337.
2006
Race/ethnicity and cancer occurrence in systemic lupus erythematosus.
53:781-784.
2005
Are health care professionals advising adults with arthritis to become more physically active?.
53:279-283.
2005
Accuracy of veterans administration databases for a diagnosis of rheumatoid arthritis.
51:952-957.
2004
Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis.
51:609-615.
2004
Effect of knee osteoarthritis on the perception of quality of life in Venezuelan patients.
51:377-382.
2004
Measuring quality in arthritis care: The arthritis foundation's quality indicator set for analgesics.
51:337-349.
2004
Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course.
51:465-474.
2004
Measuring Quality in Arthritis Care: Methods for Developing the Arthritis Foundation's Quality Indicator Set.
51:193-202.
2004
Systemic Lupus Erythematosus in Three Ethnic Groups. XVIII. Factors Predictive of Poor Compliance with Study Visits.
51:258-263.
2004
Systemic Lupus Erythematosus in Three Ethnic Groups. XIV. Poverty, Wealth, and Their Influence on Disease Activity.
51:73-77.
2004
Leflunomide Use during the First 33 Months after Food and Drug Administration Approval: Experience with a National Cohort of 3,325 Patients.
49:745-751.
2003
The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs.
49:293-299.
2003
A reply to comments on sociocultural issues in clinical research: Unraveling the Tuskegee Syphilis Study [1].
47:691.
2002
Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: A comparison of physician and patient visual analog scale scores.
47:408-413.
2002
Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory.
47:310-319.
2002
Resolved: Low-dose glucocorticoids are neither safe nor effective for the long-term treatment of rheumatoid arthritis.
45:468-471.
2001
Sociocultural issues in clinical research.
45:203-207.
2001
Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort.
45:191-202.
2001
Psychosocial and health status variables independently predict health care seeking in fibromyalgia.
45:362-371.
2001
Use of complementary and alternative medicine by older patients with arthritis: A population-based study.
45:398-403.
2001
Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study.
12:256-266.
1999
Systemic lupus erythematosus in three ethnic groups. V. Acculturation, health-related attitudes and behaviors, and disease activity in hispanic patients from the LUMINA cohort.
12:267-276.
1999
Translation to Spanish, reproducibility, and cross-cultural adaptation of the Miller-Rahe recent life change questionnaire in Venezuela.
12:287-293.
1999
